Review article · 2014 · Open access

Genomic Architecture of Pharmacological Efficacy and Adverse Events

Aparna Chhibber, Deanna L. Kroetz, Kelan G. Tantisira, Michael J. McGeachie, Cheng Cheng, Robert M. Plenge, Eli A. Stahl, Wolfgang Sadée, Marylyn DeRiggi Ritchie, Sarah A. Pendergrass

Pharmacogenomics, 15(16), 2025–2048 · Published 1 December 2014 · DOI 10.2217/pgs.14.144

Open full textView at the publisherCite this paper

In brief

“Genomic Architecture of Pharmacological Efficacy and Adverse Events” is a 2014 review article by Aparna Chhibber and 9 co-authors, published in Pharmacogenomics. OpenAlex counts 25 citations as of 21 November 2026. It is open access: the full text is free to read at PubMed Central.

Citations
25
Most cited in
2016 (6)
Field-weighted impact
0.64
References
136
Authors
10

Abstract

The pharmacokinetic and pharmacodynamic disciplines address pharmacological traits, including efficacy and adverse events. Pharmacogenomics studies have identified pervasive genetic effects on treatment outcomes, resulting in the development of genetic biomarkers for optimization of drug therapy. Pharmacogenomics-based tests are already being applied in clinical decision making. However, despite substantial progress in identifying the genetic etiology of pharmacological response, current biomarker panels still largely rely on single gene tests with a large portion of the genetic effects remaining to be discovered. Future research must account for the combined effects of multiple genetic variants, incorporate pathway-based approaches, explore gene-gene interactions and nonprotein coding functional genetic variants, extend studies across ancestral populations, and prioritize laboratory characterization of molecular mechanisms. Because genetic factors can play a key role in drug response, accurate biomarker tests capturing the main genetic factors determining treatment outcomes have substantial potential for improving individual clinical care.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Chhibber, A., Kroetz, D. L., Tantisira, K. G., McGeachie, M. J., Cheng, C., Plenge, R. M., Stahl, E. A., Sadée, W., Ritchie, M. D., & Pendergrass, S. A. (2014). Genomic Architecture of Pharmacological Efficacy and Adverse Events. Pharmacogenomics, 15(16), 2025–2048. https://doi.org/10.2217/pgs.14.144

MLA 9

Chhibber, Aparna, et al. “Genomic Architecture of Pharmacological Efficacy and Adverse Events.” Pharmacogenomics, vol. 15, no. 16, 2014, pp. 2025–2048. https://doi.org/10.2217/pgs.14.144.

Chicago

Chhibber, Aparna, Deanna L. Kroetz, Kelan G. Tantisira, Michael J. McGeachie, Cheng Cheng, Robert M. Plenge, Eli A. Stahl, Wolfgang Sadée, Marylyn DeRiggi Ritchie, and Sarah A. Pendergrass. 2014. “Genomic Architecture of Pharmacological Efficacy and Adverse Events.” Pharmacogenomics 15 (16): 2025–2048. https://doi.org/10.2217/pgs.14.144.

Harvard

Chhibber, A. et al. (2014) ‘Genomic Architecture of Pharmacological Efficacy and Adverse Events’, Pharmacogenomics, 15(16), pp. 2025–2048. doi:10.2217/pgs.14.144.

IEEE

A. Chhibber et al., “Genomic Architecture of Pharmacological Efficacy and Adverse Events,” Pharmacogenomics, vol. 15, no. 16, pp. 2025–2048, 2014, doi: 10.2217/pgs.14.144.

BibTeX

@article{chhibber2014genomic,
  title     = {{Genomic Architecture of Pharmacological Efficacy and Adverse Events}},
  author    = {Chhibber, Aparna and Kroetz, Deanna L. and Tantisira, Kelan G. and McGeachie, Michael J. and Cheng, Cheng and Plenge, Robert M. and Stahl, Eli A. and Sadée, Wolfgang and Ritchie, Marylyn DeRiggi and Pendergrass, Sarah A.},
  journal   = {Pharmacogenomics},
  year      = {2014},
  volume    = {15},
  number    = {16},
  pages     = {2025--2048},
  doi       = {10.2217/pgs.14.144},
  url       = {https://doi.org/10.2217/pgs.14.144}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Citations by year

YearCitationsShare of the best year
201522
201666
201755
201833
201933
202055
202211

Its field-weighted citation impact is 0.64: it has been cited 0.64 times as often as the average work of the same field, type and year (1.00 is the world average).

Topic and keywords

Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism

  • pharmacokinetics
  • pharmacodynamics
  • drug efficacy
  • adverse drug reactions
  • genetic biomarkers
  • pharmacogenetic testing
  • gene-gene interaction
  • ancestral populations

Work with this paper

Most-cited papers in Pharmacology, Toxicology and Pharmaceutics

All highly cited Pharmacology, Toxicology and Pharmaceutics papers

Questions about this paper

How do I cite this paper in APA style?

Chhibber, A., Kroetz, D. L., Tantisira, K. G., McGeachie, M. J., Cheng, C., Plenge, R. M., Stahl, E. A., Sadée, W., Ritchie, M. D., & Pendergrass, S. A. (2014). Genomic Architecture of Pharmacological Efficacy and Adverse Events. Pharmacogenomics, 15(16), 2025–2048. https://doi.org/10.2217/pgs.14.144

How many times has this paper been cited?

25 times, according to OpenAlex on 21 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at PubMed Central: sign in and open the full text from this page.

Who wrote this paper?

Aparna Chhibber, Deanna L. Kroetz, Kelan G. Tantisira, Michael J. McGeachie, Cheng Cheng, Robert M. Plenge, Eli A. Stahl, Wolfgang Sadée, Marylyn DeRiggi Ritchie, Sarah A. Pendergrass.

What is the DOI of this paper?

10.2217/pgs.14.144, permanently at https://doi.org/10.2217/pgs.14.144. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 21 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.